8:00 am Registration & Morning Coffee
9:00 am- 12:00 pm Workshop A
Improving Patient Selection, Recruitment & Clinical Trial Design to Advance Bacteriophage Therapies Across a Wide Range of Indications
Synopsis
As the bacteriophage field continues pushing forward, the need for pivotal clinical trials grows stronger. The design, dosing, administration, and patient recruitment are all important factors into making the trial as effective as possible. In this workshop, we will cover the questions:
- What diagnostic assays can be employed to identify and recruit relevant patients on a fast timeline?
- What dosing schedule suits bacteriophages to minimize immune response against bacteriophages?
- What different disease indications and patient populations would make the biggest impact in furthering bacteriophages through the clinic?
1:00 pm – 4:00 pm Workshop B
Spearheading the Investment Opportunities for Bacteriophage Therapies to Become the Standard of Care in Antibiotic Resistant Infections
Synopsis
Investment and funding is vital to secure for bacteriophage companies to develop effective therapies and proceed to the clinic for randomized, pivotal clinical trials. Demonstrating the untapped potential of bacteriophages to treat antibiotic-resistant infections and beyond to investors is a necessary step on the path to replacing antibiotics as the standard of care. Join us for a 3-hour session as we dive into:
- How to develop an investment strategy to address antimicrobial resistance with bacteriophages
- Rethinking the business model for bacteriophages to develop effective therapies to take to market
- Communicating the advantage of bacteriophages to funders as valid alternatives to antibiotics